Dr. Dickey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Cox 201-B
Boston, MA 02114Phone+1 617-726-1721Fax+1 617-724-9948
Education & Training
Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2014 - 2017
University of WashingtonResidency, Internal Medicine, 2011 - 2014
Vanderbilt University School of MedicineClass of 2011
Certifications & Licensure
MA State Medical License 2014 - 2025
WA State Medical License 2011 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Effect of Oral Cimetidine in the Protoporphyrias Start of enrollment: 2022 Jun 14
Roles: Sponsor-Investigator, Contact, Principal Investigator
Publications & Presentations
PubMed
- Porphyria cutanea tarda: a unique iron-related disorder.Rebecca K Leaf, Amy K Dickey
Hematology. American Society of Hematology. Education Program. 2024-12-06 - Givosiran: a targeted treatment for acute intermittent porphyria.Amy K Dickey, Rebecca K Leaf
Hematology. American Society of Hematology. Education Program. 2024-12-06 - Observational pilot study of multi-wavelength wearable light dosimetry for erythropoietic protoporphyria.Amy K Dickey, Jaime Berkovich, Rebecca K Leaf, Paul Y Jiang, Gisela Lopez-Galmiche
International Journal of Dermatology. 2024-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
